Infections during pregnancy can expose the fetus to microbial antigens leading to inflammation that affects B cell development. Prenatal fetal immune priming may have an important role in infant acquisition of pathogen specific immunity. We examined plasma pro-inflammatory biomarkers, the proportions of various B cell subsets, and fetal priming to tetanus vaccination in cord blood from human US and Kenyan neonates. US neonates had no identified prenatal infectious exposures whereas Kenyan neonates examined had congenital CMV or mothers with prenatal HIV or Plasmodium falciparum, or no identified infectious exposures. Kenyan neonates had higher levels of IP-10, TNFα, CRP, sCD14 and BAFF than US neonates. Among the Kenyan groups, neonates with prenatal infections/infectious exposures had higher levels of cord blood INFɣ, IL-7, sTNFR1 and sTNFR2 compared to neonates with no infectious exposures. Kenyan neonates had greater proportions of activated memory B cells (MBC) compared to US neonates. Among the Kenyan groups, HIV exposed neonates had greater proportions of atypical MBC compared to the other groups. Although HIV exposed neonates had altered MBC subset distributions, detection of tetanus-specific MBC from cord blood, indicative of fetal priming with tetanus vaccine given to pregnant women, was comparable in HIV exposed and non HIV exposed neonates. These results indicate that the presence of infections during pregnancy induces fetal immune activation with inflammation and increased activated MBC frequencies in neonates. The immunologic significance and long term health consequences of these differences warrants further investigation.